Evidence map›Paper›PMID 39770311›Full record

ArticlePathogens (Basel, Switzerland)2024

Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq.

Ahmed A Al-Mankhee, Yassmin Moatasim, Ahmed El Taweel, Mokhtar Gomaa, Omar A Rabiee, Marwa M Gado, Ahmed B Barakat, Mohamed A Ali, Rabeh El-Shesheny

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed A Al-MankheeAl Hussein Teaching Hospital, Al Bat'haa 64011, Thi Qar, Iraq.
Yassmin MoatasimCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0003-2159-2511
Ahmed El TaweelCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Mokhtar GomaaCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Omar A RabieeDepartment of Microbiology, Faculty of Science, Ain Shams University, Cairo 11566, Egypt.
Marwa M GadoDepartment of Microbiology, Faculty of Science, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0003-3905-5482
Ahmed B BarakatDepartment of Microbiology, Faculty of Science, Ain Shams University, Cairo 11566, Egypt.
Mohamed A AliCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0002-5615-3212
Rabeh El-SheshenyCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0002-8798-2240

Funding

Sience and Technology Development Fund (STDF) 46654
6 · The paper itself

Abstract

The COVID-19 pandemic caused by the SARS-CoV-2 virus continues to circulate worldwide, causing the deaths of millions of people. The continuous circulation of the virus, its genetic diversity, the emergence of new variants with increased transmissibility, and/or the capacity of the virus to escape from the immune system constitute a major public health concern. In our study, we aimed to characterize SARS-CoV-2 strains in Iraq from the first introduction until the end of 2023, and to identify their variants, lineages, clades, and mutation patterns. All published Iraqi full genome sequences (2020-2023) were obtained from Global Initiative on Sharing All Influenza Data (GISAID) and subjected to molecular characterization along with 19 samples of full genome sequences that were collected during the fifth and sixth waves of the SARS-CoV-2 pandemic in this study. Next-generation sequencing was performed using an Illumina MiSeq system, and phylogenetic analysis was performed for all the Iraqi sequences. Three established global platforms, GISAID, Nextstrain, and PANGO, were used for the classification of isolates into distinct clades, variants, and lineages. Six wave peaks of COVID-19 cases have been identified in Iraq, resulting in approximately 2,400,000 cumulative confirmed cases and more than 25,000 deaths. Our study revealed patterns of circulation and dominance of SARS-CoV-2 clades and their lineages in the pandemic waves in the country.

Indexed as

COVID-19Genetic VariationGenome, ViralPhylogenySARS-CoV-2Evolution, MolecularHumansIraqMutationPandemicsgenomicIraqSARS-CoV-2

Identifiers

PMID39770311
PMCPMC11728743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.